Close the second tranche of the securities purchase agreement
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 27 Jan 2021
- Due
- 31 Mar 2021
- Delivered
- 17 Mar 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“the second closing contemplated by the securities purchase agreement is expected to occur at the end of the first quarter of 2021.”
What we found
Evidence strength A What the grades mean
The company completed the second closing of the 2021 private placement on March 17, 2021, which was within the first quarter of 2021.
-
A Armata Pharmaceuticals, Inc. 10-Q filed 2021-05-13
“At the closing of the second tranche (the “Second Closing”), which was approved by the Company’s stockholders, Innoviva purchased 4,285,935 Shares and Common Warrants to purchase 4,285,935 shares of common stock for an aggregate purchase price of $13.9 million.” ✓ confirmed on the page
-
A Armata Pharmaceuticals, Inc. 10-Q filed 2021-05-13
“The Second Closing was completed on March 17, 2021.” ✓ confirmed on the page
Market reaction: the shares moved -3.5% against the S&P 500 over the three sessions around the disclosure (12 May 2021 to 17 May 2021). What this measures
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Transaction other
- Indicative materiality
- Medium rules
- Action
- Close
- Deliverable
- Second tranche of securities purchase agreement
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
- Conditional
- Yes: approval of Armata's stockholders
- Depends on
- Shareholder
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Armata Pharmaceuticals, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ARMP-022468 · Corrections policy